Home › Psychotic Disorders
Psychotic Disorders clinical trials recruiting in the U.S.
75 studies for Psychotic Disorders are recruiting participants at sites across the United States.
Psychotic disorders are severe mental disorders that cause abnormal thinking and perceptions. Two main symptoms are delusions and hallucinations. Learn more.
Cities with the most studies
- San Diego, CA10 studies
- Boston, MA9 studies
- New York City, NY6 studies
- Cambridge, MA6 studies
- Dallas, TX6 studies
- Queens, NY5 studies
- Miami, FL5 studies
- Los Angeles, CA5 studies
- Anaheim, CA4 studies
- Austin, TX4 studies
- Parma, OH4 studies
- Tampa, FL4 studies
- Hartford, CT4 studies
- Pittsburgh, PA4 studies
- Athens, GA3 studies
- Houston, TX3 studies
- Cleveland, OH3 studies
- Atlanta, GA3 studies
- Hialeah, FL3 studies
- Grand Prairie, TX3 studies
- Naples, FL3 studies
- Augusta, GA3 studies
- Orange, CA3 studies
- Bellevue, WA3 studies
- Long Beach, CA3 studies
- West Palm Beach, FL3 studies
- Orlando, FL3 studies
- Baltimore, MD3 studies
- Worcester, MA3 studies
- Minneapolis, MN3 studies
- Cape Coral, FL3 studies
- Chino, CA3 studies
- Nashville, TN3 studies
- Chicago, IL3 studies
- San Antonio, TX3 studies
By state
- Arizona3 studies
- California20 studies
- Connecticut5 studies
- Florida8 studies
- Georgia10 studies
- Illinois5 studies
- Maryland5 studies
- Massachusetts13 studies
- Michigan3 studies
- Minnesota4 studies
- New Jersey5 studies
- New York15 studies
- North Carolina4 studies
- Ohio7 studies
- Pennsylvania6 studies
- Tennessee3 studies
- Texas14 studies
- Washington4 studies
Recently updated studies
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 29, 2026 · NCT06540833State Representation in Early Psychosis 2
RecruitingObservational studyHealthy volunteers welcome
Ages 15 to 45 · All sexes · Updated Sep 22, 2026 · NCT07834203A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Aug 27, 2026 · NCT06887192Cerebellar Modulation of Cognition in Psychosis
Recruiting
Ages 18 to 55 · All sexes · Updated Aug 20, 2026 · NCT06107764Enhancing Veteran-Clinical Collaboration in VA PRRCs
Recruiting
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT06898879REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
Recruiting
Ages 18 to 50 · All sexes · Updated Aug 17, 2026 · NCT07006935Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
Recruiting
Ages 18 to 45 · All sexes · Updated Aug 17, 2026 · NCT06221852Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
RecruitingPhase 2/3
Ages 18 to 90 · All sexes · Updated Aug 12, 2026 · NCT06529029Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and Hospital
Recruiting
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07359157Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
RecruitingPhase 1
Ages 10 to 17 · All sexes · Updated Aug 11, 2026 · NCT05025605Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
Recruiting
Ages 18 to 45 · All sexes · Updated Aug 4, 2026 · NCT05890183BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
Recruiting
Ages 16 to 30 · All sexes · Updated Jul 29, 2026 · NCT07417904Determining the Role of Social Reward Learning in Social Anhedonia
Recruiting
Ages 18 to 35 · All sexes · Updated Jul 27, 2026 · NCT05617898Cognitive Strategies in Early Psychosis 2
RecruitingPhase 3
Ages 18 to 35 · All sexes · Updated Jul 23, 2026 · NCT07263022Transition Care for FEP
RecruitingObservational study
Ages 18 to 40 · All sexes · Updated Jul 20, 2026 · NCT07713849Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness
RecruitingHealthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Jul 16, 2026 · NCT04940663MicroRNAs as Biomarkers in First Episode Schizophrenia
RecruitingHealthy volunteers welcome
Ages 15 to 40 · All sexes · Updated Jul 14, 2026 · NCT07703670Exercise and Olanzapine-samidorphan
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Jul 13, 2026 · NCT06740890Anticholinergic Deprescription in Schizophrenia
RecruitingPhase 4Healthy volunteers welcome
Ages 40 to 70 · All sexes · Updated Jul 10, 2026 · NCT06562608A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
Recruiting
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05537376Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
RecruitingHealthy volunteers welcome
All ages · All sexes · Updated Jul 9, 2026 · NCT03906435Acetazolamide for Treatment Resistant Schizophrenia
RecruitingPhase 1/2
Ages 18 to 55 · All sexes · Updated Jul 7, 2026 · NCT04887792From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.